Table 1 Procedures and liver tumor pathology of patients who underwent minor minimally invasive liver surgery (MILS) with or without a falciform ligament flap (FLF) for sealing the resection surface.

From: A falciform ligament flap surface sealing technique for laparoscopic and robotic-assisted liver surgery

 

MILS + FLF n (%)

MILS—FLF n (%)

Total n (%)

Type of liver resection (p = 0.611)

Left lateral LR

17 (56.7)

7 (43.8)

24 (52.2)

Anatomical liver segment resection

7 (23.3)

5 (31.3)

12 (26.1)

Bisegmentectomy

2 (6.7)

3 (18.8)

5 (10.9)

Atypical one-segment resection

3 (10.0)

1 (6.3)

4 (8.7)

Anatomic resection of two liver segments

1 (3.3)

0 (0.0)

1 (2.2)

Total

30 (100.0)

16 (100.0)

46 (100.0)

Type of liver lesion (p = 0.305)

HCC

9 (30.0)

2 (12.5)

11 (23.9)

Colorectal metastases

8 (26.7)

3 (18.8)

11 (23.9)

FNH

5 (16.7)

3 (18.8)

8 (17.4)

CCA

1 (3.3)

2 (12.5)

3 (6.5)

Liver cyst

1 (3.3)

2 (12.5)

3 (6.5)

Hepatic adenoma

2 (6.7)

1 (6.3)

3 (6.5)

Uveal melanoma metastasis

2 (6.7)

0 (0.0)

2 (4.3)

Liver hemangioma

1 (3.3)

0 (0.0)

1 (2.2)

GIST metastasis

1 (3.3)

0 (0.0)

1 (2.2)

Metastasis of yolk sac tumor

0 (0.0)

1 (6.3)

1 (2.2)

Metastasis of ovarian carcinoma

0 (0.0)

1 (6.3)

1 (2.2)

Metastasis of hypopharyngeal carcinoma

0 (0.0)

1 (6.3)

1 (2.2)

Total

30 (100.0)

16 (100.0)

46 (100.0)

  1. CCA cholangiocellular carcinoma, FLF falciform ligament flap, FNH focal nodular hyperplasia, GIST gastrointestinal stromal tumor, HCC hepatocellular carcinoma, LR liver resection, MILS minimally invasive liver surgery.